Age | 岁 |
patients with coronary heart disease | |
Sign the informed consent | |
Risk stratification for patients with low or middle risk |
Patients in one of the following condition are excluded |
Name |
|
gender |
|
people |
|
Height | cm |
weight | kg |
abdomen circumference | cm |
left ventricular ejection fraction(LVEF) |
|
stents implanted | |
anamnesis | |
Body Mass Index | kg/m2 |
smoking history | |
blood cholesterol level in hospital | mmol/l |
drink history | |
Bad mood performance | |
exercise habit | |
The drug |
heart rate in anaerobic domain | 次/分 |
heart rate in the peak oxygen uptake | 次/分 |
blood pressure in Anaerobic domain | mm/Hg |
blood pressure in the peak oxygen uptake | mm/Hg |
the oxygen uptake in the rest | ml/kg/min |
the oxygen uptake in anaerobic threshold | ml/kg/min |
Peak oxygen uptake | ml/kg/min |
target heart rate | 次/分 |
Treadmill load | w |
blood pressure in the rest | 次/分 |
blood pressure in the rest | mm/Hg |
Phosphodiesterase 9A | ng/ml |
Inflammatory factors | ng/ml |
Immune-modulatory marker | ng/ml |
left ventricular dysfunction marker | ng/ml |
myeloperoxidase | ng/ml |
adiponectin | ng/ml |
extracellular-matrix remodeling markers | ng/ml |
heart rate in anaerobic domain | 次/分 |
heart rate in the peak oxygen uptake | 次/分 |
blood pressure in the rest | mm/Hg |
blood lipid level in Peak oxygen uptake period | mm/Hg |
the oxygen uptake in the rest | ml/kg/min |
the oxygen uptake in anaerobic threshold | ml/kg/min |
Peak oxygen uptake | ml/kg/min |
target heart rate | 次/分 |
Treadmill load | w |
heart rate in the rest | 次/分 |
blood pressure in the rest | mm/Hg |
Phosphodiesterase 9A | ng/ml |
Inflammatory factors | ng/ml |
Immune-modulatory marker | ng/ml |
left ventricular dysfunction marker | ng/ml |
myeloperoxidase | ng/ml |
adiponectin | ng/ml |
extracellular-matrix remodeling markers | ng/ml |
Patients with follow-up of 3 months is discomfort or not | |
stick to exercise or not in the follow-up after 3 months |